Albert David Limited - Manufacturing Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms, Bulk Drugs and Disposable Syringes & Needles

Disclosure under Regulation 30
	Outcome of Board Meeting on 14th November 2024

	Outcome of Board Meeting on 09th August 2024

	Outcome of Postal Ballot on May 18, 2024

	Outcome of Board Meeting on May 13, 2024

	RESIGNATIONINTIMATION

	Notice dt. 22.04.24 to Shareholders under IEPF Rules

	Postal Ballot Notice dated 16.04.2024

	Board's Resolution by Circulated on 1st April 2024

	Retirement of Independent Directors effective 1st April 2024

	Outcome of Board Meeting dt. 14-03-2024

	Clarification dated 03-Feb-24 in response to query dated 02-Feb-24 on outcome of board meeting dated 10-Aug-23

	Clarification on Price Movement dt. 29-01-2024

	Outcome of Postal Ballot - Dec 16, 2023

	Resignation of Company Secretary & Compliance Officer

	Outcome of Board Meeting on 9th November, 2023

	Outcome Results 09.11.2023

	Outcome of the Circular Resolution passed by the Board on 01st November 2023

	Outcome of the Circular Resolution passed by the Board on 01st November 2023

	Outcome of Board Meeting held on 10th Aug'23

	Change in details of KMPs for disclosing material information under Regulation 30

	Appointment of Chief Executive Officer, Company Secretary & Compliance Officer

	Reconstitution of Committee

	Resignation of MD & CEO

	Appointment of Mr. A. V. Kothari as Non-Executive Director

	Re-affirmation of Credit Rating - 30.04.2022

	Re-affirmation of Credit Rating

	Updated contact details of KMPs authorised to determine & disclose Material Events

	Disclosure dated November 11, 2020 under Regulation 30 LODR

	Appointment of Dr. Monjori Mitra as Independent Director

	Updated contact details of KMPs authorised to determine & disclose Material Events

	Cessation of Company Secretary & Compliance Officer

	Appointment of Company Secretary & Compliance Officer

	Impact of COVID-19 pandemic on the Company

	Non-applicability of SEBI's Large Corporate Circular - 27.05.2020

	Announcement pursuant to Covid-19

	Board approves Interim Dividend for FY 2019-2020

	Record date for Interim Dividend for FY 2019-2020

	Non-applicability of SEBI's Large Corporate Circular - 20.04.2019

	Re-affirmation of Credit Rating

	Proceedings' of Postal Ballot 2019

	Disclosure under Regulation 30 & Ors. of Listing Regulations

	Retirement of Dr. A. K. Bhattacharya wef 01.04.2019

	Disposal of Mandideep Unit

	Appointment of Executive Chairman and MD & CEO w.e.f. 1st April, 2018

	Closure of Mandideep Unit

	Clarification to NSE - Mandideep Unit

	Outcome of Board Meeting dated 30 Oct 2017

	Outcome of the Board Meeting held on 30th May 2017

	Outcome of the Board Meeting held on 13th August 2016

	Appointment of Mr. H P Kabra as Additional & Whole time Director on 1st July 2016

	Outcome of the Board Meeting held on 30th May 2016

	Outcome of the Board Meeting held on 28th March 2016

	Outcome of the Board Meeting held on 14th March 2016

	Vacation of Directorship - Dr. K. Lahiri

	Updated CRISIL Rating

	Change in Address of Registered / Head Office

	Appointment of CEO

	CRISIL Rating

	AGM Proceedings 2016

	Actibile